Prosensa

Clinical trials kick offs and content management

Pimento was commissioned to organise an Investigator Meeting of a clinical study for the Dutch biopharmaceutical company Prosensa who have been working on the development and commercialization of RNA based therapeutics for Duchenne Muscular Dystrophy (DMD). DMD is a severely debilitating childhood neuromuscular disease that affects one in 3,500 new born boys. To date we have managed three Investigator Meetings in Belgium and Chicago attended by delegates from across the world. Each took place over 4 days was attended by 80 delegates – doctors, physiotherapists, clinical researchers etc.
Back to our work